Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Segawa T, Kamoto T, Kinoshita H, Kunishima Y, Yoshimura K, Ito A, Takahashi T, Higashi S, Nakamura E, Nishiyama H, Ito N, Yamamoto S, Habuchi T, Ogawa O.
Segawa T, et al. Among authors: nishiyama h.
Int J Clin Oncol. 2005 Oct;10(5):333-7. doi: 10.1007/s10147-005-0513-x.
Int J Clin Oncol. 2005.
PMID: 16247660
Clinical Trial.